glycolaldehyde has been researched along with Cardiovascular Diseases in 3 studies
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Haesen, S | 2 |
Cöl, Ü | 1 |
Schurgers, W | 1 |
Evens, L | 2 |
Verboven, M | 2 |
Driesen, RB | 2 |
Bronckaers, A | 1 |
Lambrichts, I | 2 |
Deluyker, D | 2 |
Bito, V | 2 |
Kuster, D | 1 |
Beliën, H | 1 |
van der Velden, J | 1 |
Domingo-Espín, J | 1 |
Nilsson, O | 1 |
Bernfur, K | 1 |
Del Giudice, R | 1 |
Lagerstedt, JO | 1 |
3 other studies available for glycolaldehyde and Cardiovascular Diseases
Article | Year |
---|---|
Glycolaldehyde-modified proteins cause adverse functional and structural aortic remodeling leading to cardiac pressure overload.
Topics: Acetaldehyde; Acetylcholine; Animals; Aorta; Blood Pressure; Cardiovascular Diseases; Collagen; Cycl | 2020 |
Glycolaldehyde-Derived High-Molecular-Weight Advanced Glycation End-Products Induce Cardiac Dysfunction through Structural and Functional Remodeling of Cardiomyocytes.
Topics: Acetaldehyde; Animals; Aorta; Cardiovascular Diseases; Diastole; Glycation End Products, Advanced; H | 2020 |
Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism.
Topics: Acetaldehyde; Animals; Apolipoprotein A-I; Blood Glucose; Cardiovascular Diseases; Cell Line; Choles | 2018 |